JPS6348858B2 - - Google Patents
Info
- Publication number
- JPS6348858B2 JPS6348858B2 JP11548380A JP11548380A JPS6348858B2 JP S6348858 B2 JPS6348858 B2 JP S6348858B2 JP 11548380 A JP11548380 A JP 11548380A JP 11548380 A JP11548380 A JP 11548380A JP S6348858 B2 JPS6348858 B2 JP S6348858B2
- Authority
- JP
- Japan
- Prior art keywords
- isom
- lactone
- compound
- formula
- substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229910052783 alkali metal Inorganic materials 0.000 claims description 9
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- 150000001340 alkali metals Chemical class 0.000 claims description 3
- AJLFOPYRIVGYMJ-INTXDZFKSA-N mevastatin Chemical class C([C@H]1[C@@H](C)C=CC2=CCC[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 AJLFOPYRIVGYMJ-INTXDZFKSA-N 0.000 claims description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 21
- -1 ML-236B lactone Chemical class 0.000 description 21
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 15
- 239000000126 substance Substances 0.000 description 15
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 13
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 150000002596 lactones Chemical class 0.000 description 12
- 238000000034 method Methods 0.000 description 11
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 238000000862 absorption spectrum Methods 0.000 description 8
- 239000000284 extract Substances 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 235000012000 cholesterol Nutrition 0.000 description 6
- 230000000813 microbial effect Effects 0.000 description 6
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 6
- 238000004809 thin layer chromatography Methods 0.000 description 6
- 125000005907 alkyl ester group Chemical group 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 241000293029 Absidia caerulea Species 0.000 description 4
- 241001061260 Emmelichthys struhsakeri Species 0.000 description 4
- 241000736855 Syncephalastrum racemosum Species 0.000 description 4
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 150000004702 methyl esters Chemical class 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 241000813867 Streptomyces roseochromogenus Species 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 102100029077 3-hydroxy-3-methylglutaryl-coenzyme A reductase Human genes 0.000 description 2
- 241000235555 Cunninghamella Species 0.000 description 2
- 241001290628 Cunninghamella echinulata Species 0.000 description 2
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- CABVTRNMFUVUDM-VRHQGPGLSA-N (3S)-3-hydroxy-3-methylglutaryl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C[C@@](O)(CC(O)=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 CABVTRNMFUVUDM-VRHQGPGLSA-N 0.000 description 1
- 101710158485 3-hydroxy-3-methylglutaryl-coenzyme A reductase Proteins 0.000 description 1
- 241000235389 Absidia Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229940113549 Cholesterol inhibitor Drugs 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108090000895 Hydroxymethylglutaryl CoA Reductases Proteins 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 1
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 1
- XCOBLONWWXQEBS-KPKJPENVSA-N N,O-bis(trimethylsilyl)trifluoroacetamide Chemical compound C[Si](C)(C)O\C(C(F)(F)F)=N\[Si](C)(C)C XCOBLONWWXQEBS-KPKJPENVSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 235000002233 Penicillium roqueforti Nutrition 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 241000736854 Syncephalastrum Species 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 239000012084 conversion product Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000006884 silylation reaction Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pyrane Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (23)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11548380A JPS57108039A (en) | 1980-08-22 | 1980-08-22 | Ml-236b derivative |
| DK247081A DK149080C (da) | 1980-06-06 | 1981-06-04 | Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre |
| MX819478U MX7065E (es) | 1980-06-06 | 1981-06-04 | Un procedimiento microbiologico para preparar derivados de ml-236b |
| AU71376/81A AU549988B2 (en) | 1980-06-06 | 1981-06-05 | Hydroxy esters |
| FI811762A FI71168C (fi) | 1980-06-06 | 1981-06-05 | Foerfarande foer framstaellning av ml-236b-derivat vilka anvaends som laekemedel |
| US06/270,846 US4346227A (en) | 1980-06-06 | 1981-06-05 | ML-236B Derivatives and their preparation |
| DE19813122499 DE3122499A1 (de) | 1980-06-06 | 1981-06-05 | Neue derivate von ml-236b, verfahren zu ihrer herstellung und diese derivate enthaltende arzneimittelzubereitungen |
| ES502827A ES8300353A1 (es) | 1980-06-06 | 1981-06-05 | Procedimiento de preparar acidos hidroxicarboxilicos y sus derivados. |
| SE8103560A SE453389B (sv) | 1980-06-06 | 1981-06-05 | Hydroxikarboxylsyror, ringslutna laktoner, salter och estrar derav samt forfarande for framstellning av nemnda foreningar |
| FR8111190A FR2483912B1 (fr) | 1980-06-06 | 1981-06-05 | Derives hydroxycarboxyles du compose ml-236b, leur procede de preparation et leur application therapeutique |
| KR1019810002023A KR840001055B1 (ko) | 1980-06-06 | 1981-06-05 | Ml-236b 유도체의 제조방법 |
| NL8102737A NL191738C (nl) | 1980-06-06 | 1981-06-05 | ML-236B-derivaten, werkwijze voor hun bereiding en farmaceutische preparaten, die deze derivaten bevatten. |
| CH3722/81A CH655090A5 (de) | 1980-06-06 | 1981-06-05 | Hexahydronaphthalinderivate und ihre herstellung. |
| IT67777/81A IT1144598B (it) | 1980-06-06 | 1981-06-05 | Composti farmaceutici atti ad inibire la biosintesi del colesterolo e procedimento per la loro preparazione |
| IE1257/81A IE51270B1 (en) | 1980-06-06 | 1981-06-05 | Ml-236b derivatives and their preparation |
| GB8117450A GB2077264B (en) | 1980-06-06 | 1981-06-08 | Ml-236b derivatives and their preparation |
| CA000379232A CA1150170A (en) | 1980-06-06 | 1981-06-08 | Ml-236b derivatives and their preparation |
| BE0/205046A BE889150A (fr) | 1980-06-06 | 1981-06-09 | Derives hydroxycarboxyles du compose ml-236b, leur procede de preparation et leur application therapeutique |
| AT0256781A AT374495B (de) | 1980-06-06 | 1981-06-09 | Verfahren zur herstellung neuer derivate der verbindung ml-236b |
| US06/351,974 US4410629A (en) | 1980-06-06 | 1982-02-24 | ML-236B Derivatives and their preparation |
| US06/351,975 US4448979A (en) | 1980-06-06 | 1982-02-24 | ML-236B Derivatives |
| MX9203563A MX9203563A (es) | 1980-06-06 | 1992-06-26 | Derivados de ml-236b y su preparacion. |
| NL960028C NL960028I2 (nl) | 1980-06-06 | 1996-11-18 | ML-236B-derivaten, werkwijze voor hun bereiding enfarmaceutische preparaten, die deze derivaten bevatten. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11548380A JPS57108039A (en) | 1980-08-22 | 1980-08-22 | Ml-236b derivative |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS57108039A JPS57108039A (en) | 1982-07-05 |
| JPS6348858B2 true JPS6348858B2 (da) | 1988-09-30 |
Family
ID=14663630
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11548380A Granted JPS57108039A (en) | 1980-06-06 | 1980-08-22 | Ml-236b derivative |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS57108039A (da) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0613455Y2 (ja) * | 1989-03-17 | 1994-04-06 | 矢崎総業株式会社 | 入出路一体型ガスメータ |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100450562B1 (ko) * | 2001-09-29 | 2004-09-30 | 코바이오텍 (주) | 프라바스타틴의 전구체 및 그 유도체의 생산 방법 |
-
1980
- 1980-08-22 JP JP11548380A patent/JPS57108039A/ja active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0613455Y2 (ja) * | 1989-03-17 | 1994-04-06 | 矢崎総業株式会社 | 入出路一体型ガスメータ |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS57108039A (en) | 1982-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4346227A (en) | ML-236B Derivatives and their preparation | |
| JPH0371419B2 (da) | ||
| Serizawa et al. | Microbial hydroxylation of ML-236B (compactin) and monacolin K (MB-530B) | |
| JPH0371116B2 (da) | ||
| Kingston et al. | Biosynthesis of antibiotics of the virginiamycin family. 3. Biosynthesis of virginiamycin M1 | |
| JPS6113699B2 (da) | ||
| JPH023623A (ja) | 抗高コレステロール血症剤 | |
| JPS6348858B2 (da) | ||
| JPH0354103B2 (da) | ||
| JPS6355502B2 (da) | ||
| ENDO et al. | Microbial phosphorylation of compactin (ML-236B) and related compounds | |
| JPS6254476B2 (da) | ||
| JPH0355471B2 (da) | ||
| US4036876A (en) | 18- AND 19-Hydroxylated prostaglandins | |
| JPH0333698B2 (da) | ||
| JPS6321672B2 (da) | ||
| JPS6328595B2 (da) | ||
| KR840001055B1 (ko) | Ml-236b 유도체의 제조방법 | |
| JPH0367075B2 (da) | ||
| JP3217301B2 (ja) | 光学活性グリシド酸エステル及び光学活性グリセリン酸エステルの製造方法 | |
| US3634461A (en) | Spirostan derivative | |
| JPH04228092A (ja) | 光学活性な２級アルコール化合物の製造方法 | |
| JPH07241197A (ja) | ２５−ヒドロキシビタミンｄ類の製造法 | |
| Mantle et al. | The role of monic acid A in pseudomonic acid A biosynthesis in Pseudomonas fluorescens | |
| JPH0482135B2 (da) |